DCC-3009
NCT06630234
Deciphera Pharmaceuticals · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.
GIST
Programs, trials, and reported response and survival for gastrointestinal stromal tumor.
DCC-3009
Deciphera Pharmaceuticals · Phase 1/2 · Recruiting · Enrollment 120
| Arm | Reported safety |
|---|
A count stays a count. This page does not turn a count into a percent.